{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:17:53Z","timestamp":1756570673869},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,18]]},"DOI":"10.7759\/cureus.49033","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T07:53:48Z","timestamp":1700380428000},"source":"Crossref","is-referenced-by-count":2,"title":["An Unusual Case of Eosinophilic Chronic Rhinosinusitis With Concurrent Eosinophilic Otitis Media: Limited Responsiveness to Multiple Antibody Therapies and Subsequent Cochlear Implantation"],"prefix":"10.7759","author":[{"given":"Kosuke","family":"Urabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Inohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2023.08.002","article-title":"The current findings in eosinophilic chronic rhinosinusitis","author":"Tsuda T","year":"2023","unstructured":"Tsuda T, Suzuki M, Kato Y, Kidoguchi M, Kumai T, Fujieda S, Sakashita M. The current findings in eosinophilic chronic rhinosinusitis. Auris Nasus Larynx. 2023, 10.1016\/j.anl.2023.08.002","journal-title":"Auris Nasus Larynx"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens WJ","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al.. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020, 58:1-464. 10.4193\/Rhin20.600","journal-title":"Rhinology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study","volume":"70","author":"Tokunaga T","year":"2015","unstructured":"Tokunaga T, Sakashita M, Haruna T, et al.. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy. 2015, 70:995-1003. 10.1111\/all.12644","journal-title":"Allergy"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2010.11.016","article-title":"Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease","volume":"38","author":"Iino Y","year":"2011","unstructured":"Iino Y, Tomioka-Matsutani S, Matsubara A, Nakagawa T, Nonaka M. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx. 2011, 38:456-61. 10.1016\/j.anl.2010.11.016","journal-title":"Auris Nasus Larynx"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin22.200","article-title":"Evaluating treatment response to mepolizumab in patients with severe CRSwNP","volume":"61","author":"Hopkins C","year":"2023","unstructured":"Hopkins C, Han JK, Lund VJ, et al.. Evaluating treatment response to mepolizumab in patients with severe CRSwNP. Rhinology. 2023, 61:108-17. 10.4193\/Rhin22.200","journal-title":"Rhinology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (Liberty NP SINUS-24 and Liberty NP SINUS- 52): results from two multicentre, randomized, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert C","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, et al.. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (Liberty NP SINUS-24 and Liberty NP SINUS- 52): results from two multicentre, randomized, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019, 394:1638-50. 10.1016\/S0140-6736(19)31881-1","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60967-2","article-title":"Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma","volume":"97","author":"Iino Y","year":"2006","unstructured":"Iino Y, Nagamine H, Kakizaki K, Komiya T, Katano H, Saruya S, Kodera K. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann Allergy Asthma Immunol. 2006, 97:761-6. 10.1016\/S1081-1206(10)60967-2","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000538","article-title":"Treatment for eosinophilic otitis media","volume":"9","author":"Matsubara A","year":"2018","unstructured":"Matsubara A, Takahata J, Miura T, Kudo N. Treatment for eosinophilic otitis media. Journal of Clinical & Cellular Immunology. 2018, 9:10.4172\/2155-9899.1000538","journal-title":"Journal of Clinical & Cellular Immunology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/00016489.2013.868601","article-title":"Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media","volume":"134","author":"Iino Y","year":"2014","unstructured":"Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media. Acta Otolaryngol. 2014, 134:366-72. 10.3109\/00016489.2013.868601","journal-title":"Acta Otolaryngol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2023.03.007","article-title":"Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis","volume":"72","author":"Nakashima D","year":"2023","unstructured":"Nakashima D, Nakayama T, Minagawa S, et al.. Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis. Allergol Int. 2023, 72:557-63. 10.1016\/j.alit.2023.03.007","journal-title":"Allergol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2020.101135","article-title":"Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: a case report","volume":"30","author":"Kagoshima H","year":"2020","unstructured":"Kagoshima H, Hori R, Kojima T, et al.. Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: a case report. Respir Med Case Rep. 2020, 30:101135. 10.1016\/j.rmcr.2020.101135","journal-title":"Respir Med Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01526-6","article-title":"NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"21","author":"Menzies-Gow A","year":"2020","unstructured":"Menzies-Gow A, Colice G, Griffiths JM, et al.. NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma. Respir Res. 2020, 21:266. 10.1186\/s12931-020-01526-6","journal-title":"Respir Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/204393-an-unusual-case-of-eosinophilic-chronic-rhinosinusitis-with-concurrent-eosinophilic-otitis-media-limited-responsiveness-to-multiple-antibody-therapies-and-subsequent-cochlear-implantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:28Z","timestamp":1707508348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/204393-an-unusual-case-of-eosinophilic-chronic-rhinosinusitis-with-concurrent-eosinophilic-otitis-media-limited-responsiveness-to-multiple-antibody-therapies-and-subsequent-cochlear-implantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.49033","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,18]]}}}